Melanotan II in Philadelphia, Pennsylvania

Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (a-MSH) developed at the University of Arizona. It acts on multiple melanocortin receptors, producing effects on skin pigmentation, sexual arousal, appetite, and fat metabolism. Originally researched as a tanning agent to reduce UV-related skin damage risk, Melanotan II gained attention for its broad melanocortin receptor activity. It is the parent compound from which PT-141 (Bremelanotide) was subsequently derived. Due to its multiple receptor interactions, Melanotan II produces a broader and less selective range of effects compared to more targeted melanocortin peptides.

While our directory is continuously growing, Philadelphia residents can explore peptide therapy options through both local providers and telehealth services. When selecting a Melanotan II provider in Philadelphia, prioritize clinics with specific peptide therapy experience, transparent pricing, and proper medical oversight. Many Philadelphia patients also have access to telehealth peptide providers who can offer competitive pricing and convenient consultations.